Your browser doesn't support javascript.
loading
YKL-40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma.
James, Anna J; Nordlund, Björn; Konradsen, Jon R; Ebersjö, Christina; Dahlén, Sven-Erik; Berggren Broström, Eva; Hedlin, Gunilla.
Afiliação
  • James AJ; Experimental Asthma and Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Nordlund B; Astrid Lindgren Children's Hospital, Lung and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden.
  • Konradsen JR; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Ebersjö C; Astrid Lindgren Children's Hospital, Lung and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden.
  • Dahlén SE; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Berggren Broström E; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Hedlin G; Sach's Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
Acta Paediatr ; 110(2): 641-642, 2021 02.
Article em En | MEDLINE | ID: mdl-32772428

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Asma / Displasia Broncopulmonar Limite: Child / Humans / Newborn Idioma: En Revista: Acta Paediatr Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Asma / Displasia Broncopulmonar Limite: Child / Humans / Newborn Idioma: En Revista: Acta Paediatr Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia